Abbott Laboratories (ABT) Net Shares Issued and Repurchased (2010 - 2022)

Abbott Laboratories has disclosed Net Shares Issued and Repurchased across 13 years of filings, most recently posting $2.6 million for Q1 2022.

• In Q1 2022, Net Shares Issued and Repurchased fell 3.71% year-over-year to $2.6 million; the TTM figure through Mar 2022 stood at $2.6 million (down 3.71% YoY), while the FY2021 annual figure was $2.9 million, down 28.65% from the prior year.
• Net Shares Issued and Repurchased came in at $2.6 million for Q1 2022 at Abbott Laboratories, down from $2.9 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $5.8 million in Q4 2018 to a low of $2.6 million in Q1 2022.
• Average Net Shares Issued and Repurchased over 5 years is $4.0 million, with a median of $4.0 million recorded in 2019.
• Year-over-year, Net Shares Issued and Repurchased surged 36.72% in 2018 and sank 31.91% in 2021.
• Over 5 years, Net Shares Issued and Repurchased stood at $5.8 million in 2018, then declined by 20.5% to $4.6 million in 2019, then dropped by 12.31% to $4.0 million in 2020, then retreated by 28.65% to $2.9 million in 2021, then slipped by 9.46% to $2.6 million in 2022.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $2.6 million in Q1 2022, $2.9 million in Q4 2021, and $2.7 million in Q1 2021.